Skip to main content
SpringerLink
Log in

Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication)

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

To evaluate possible differences between patients with refractory duodenal ulcers and those with duodenal ulcers that respond to standard doses of antisecretory medications, we determined basal acid outputs by nasogastric suction and daily smoking histories in 75 patients with endoscopically documented active duodenal ulcers. Patients were treated for at least eight weeks with standard doses of antisecretory medications and endoscopic healing or nonhealing was documented. Fifty-five patients that had complete healing of their duodenal ulcers had a mean basal acid output of 6.6±5.3 meqlhr, and 18/55 had daily cigarette smoking histories, whereas 20 patients that had nonhealing duodenal ulcers had a mean basal acid output of 20.0±9.6 meq/hr, and 8/20 had daily cigarette smoking histories. There were no significant differences between the two groups with regard to age, duodenal ulcer size, or cigarette smoking history. However, there were significant differences in male-female ratio (P <0.02) and in mean basal acid output (P < 0.001), and all patients with nonhealing duodenal ulcers had basal acid outputs of greater than 10.0 meqlhr. Patients with nonhealing duodenal ulcers were treated with increased doses of ranitidine, mean 675 mg/day (range 600–1200 mg/day), and all had complete healing endoscopically documented. These results indicate that patients treated with standard doses of antisecretory medications with nonhealing duodenal ulcers have increased basal acid outputs of greater than 10.0 meq/hr, and the duodenal ulcers heal with increased doses of antisecretory medication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Collen MJ, Hanan MR, Maher JA, et al: Cimetidine vs placebo in duodenal ulcer therapy: Six-week controlled double-blind investigation without any antacid therapy. Dig Dis Sci 25:744–749, 1980

    PubMed  Google Scholar 

  2. McCullough AJ: A multicenter, randomized double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease. Am J Med 81:17–24, 1986

    PubMed  Google Scholar 

  3. Lauritsen K, Rune SJ, Bytzer P, et al: Effect of omeprazole and cimetidine on duodenal ulcer: A double-blind comparative trial. N Engl J Med 312:958–961, 1985

    PubMed  Google Scholar 

  4. Ippoliti AF: Prognostic factors in ulcer disease: Are they real, are they relevant? J Clin Gastroenterol 7:445–446, 1985

    PubMed  Google Scholar 

  5. Raufman J-P, Collins SM, Pandol SJ, et al: Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome. Gastroenterology 84:108–113, 1983

    PubMed  Google Scholar 

  6. Collen MJ, Howard JM, McArthur KE, et al: Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann Inter Med 100:52–58, 1984

    Google Scholar 

  7. Cargill JM, Peden N, Saunders JHB, Wormsley KG: Very long term treatment of peptic ulcer with cimetidine. Lancet 2:1113–1115, 1978

    PubMed  Google Scholar 

  8. Gledhill T, Buck M, Hunt RH: Effect of no treatment, cimetidine 1 g/day, cimetidine 2 g/day and cimetidine combined with atropine on noctural gastric secretion in cimetidine non-responders. Gut 25:1211–1216, 1984

    PubMed  Google Scholar 

  9. Hetzel DJ, Hansky J, Shearman DJC, et al: Cimetidine treatment of duodenal ulceration: Short-term clinical trial and maintenance study. Gastroenterology 74:389–392, 1978

    PubMed  Google Scholar 

  10. Strom M, Berstad A, Bodemar G, Walan A: Results of short- and long-term cimetidine treatment in patients with juxtapyloric ulcers, with special reference to gastric acid and pepsin secretion. Scand J Gastroenterol 21:521–530, 1986

    PubMed  Google Scholar 

  11. Quatrini M, Basilisco G, Bianchi PA: Treatment of “cimetidine-resistant” chronic duodenal ulcers with ranitidine or cimetidine: A randomized multicenter study. Gut 25:1113–1117, 1984

    PubMed  Google Scholar 

  12. Peterson WL, Sturdevant RAL, Frankl HD, et al: Healing of duodenal ulcer with an antacid regimen. N Engl J Med 297:341–345, 1977

    PubMed  Google Scholar 

  13. Feldman M, Richardson CT: Gastric acid secretion in humans.In Physiology of the Gastrointestinal Tract, Vol 1. LR Johnson (ed). New York, Raven Press, 1981, pp 693–707

    Google Scholar 

  14. Kirkpatrick PM, Hirschowitz BI: Duodenal ulcer with unexplained marked basal gastric acid hypersecretion. Gastroenterology 79:4–10, 1980

    PubMed  Google Scholar 

  15. Farley A, Levesque D, Pare P, et al: A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer. Am J Gastroenterol 80:665–668, 1985

    PubMed  Google Scholar 

  16. Van Deventer G, Fullman H, Schneidman D, Walsh J: Predictors and delayed ulcer healing in an efficacy trial of sucralfate and cimetidine alone and in combination for treatment of active duodenal ulcer (DU). Gastroenterology (abstract) 88:1623, 1985

    Google Scholar 

  17. Lam SK, Hui WM, Lau WY, et al: Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. Gastroenterology 92:1193–1201, 1987

    PubMed  Google Scholar 

  18. Korman MG, Hansky J, Eaves ER, Schmidt GT: Influence of cigarette smoking on healing and relapse in duodenal ulcer disease. Gastroenterology 85:871–874, 1983

    PubMed  Google Scholar 

  19. Sonnenberg A, Muller-Lissner SA, Vogel E, et al: Predictors of duodenal ulcer healing and relapse. Gastroenterology 81:1061–1067, 1981

    PubMed  Google Scholar 

  20. Colin-Jones DG, Ireland A, Gear P: Reducing overnight secretion of acid to heal duodenal ulcers: Comparison of standard divided dose of ranitidine with a single dose administered at night. Am J Med 77:116–122, 1984

    PubMed  Google Scholar 

  21. Lam S-K, Lai C-L, Lee LNW, Fok K-H, Ng MMT, Siu K-F: Factors influencing healing of duodenal ulcer: Control of nocturnal secretion by H2 blockade and characteristics of patients who failed to heal. Dig Dis Sci 30:45–51, 1985

    PubMed  Google Scholar 

  22. Lee FI, Reed PR, Crowe JP, McIsaac RL, Wood JR: Acute treatment of duodenal ulcer: A multicenter study to compare ranitidine 150 mg twice daily with ranitidine 300 mg once at night. Gut 27:1091–1095, 1986

    PubMed  Google Scholar 

  23. Guslandi M.: More about refractory duodenal ulcers. Gut 25:1433–1434, 1984

    PubMed  Google Scholar 

  24. Bardhan KD, Saul DM, Edwards JL, et al: Comparison of two doses of cimetidine and placebo in the treatment of duodenal ulcer: A multicenter trial. Gut 20:68–74, 1979

    PubMed  Google Scholar 

  25. Jensen RT, Gardner JD, Raufman J-P, Pandol SJ, Doppman JL, Collen MJ: Zollinger-Ellison syndrome: Current concepts and management. Ann Intern Med 98:59–75, 1983

    PubMed  Google Scholar 

  26. Howard JM, Chremos AN, Collen MJ, et al: Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: Comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. Gastroenterology 88:1026–1033, 1985

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Medicine, Georgetown University Medical Center, 20007, Washington, DC

    Martin J. Collen MD, Valerie J. Stanczak RN, BSN & Cecelia A. Ciarleglio RN

Authors
  1. Martin J. Collen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valerie J. Stanczak RN, BSN
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cecelia A. Ciarleglio RN
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Collen, M.J., Stanczak, V.J. & Ciarleglio, C.A. Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication). Digest Dis Sci 34, 233–237 (1989). https://doi.org/10.1007/BF01536057

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01536057

Key words

Search

Navigation